XML 35 R24.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENT (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table sets forth the Company's financial instruments that were measured at fair value on a recurring basis at March 31, 2026 and December 31, 2025, by level within the fair value hierarchy:

March 31, 2026

Level 1
Level 2
Level 3
Total
Financial assets:
Debt interest rate conversion feature
202
202 
Total financial assets
$
$
$
202
$
202
Investment in unconsolidated entity:
$
$
$
8,600
$
8,600
Financial liabilities:
Debt conversion option
$
$
13,779
$
$
13,779 

December 31, 2025

Level 1
Level 2
Level 3
Total
Financial assets:
Debt interest rate conversion feature
211
211 
Total financial assets
$
$
$
211
$
211
Investment in unconsolidated entity:
$
$
$
8,800
$
8,800
Financial liabilities:
Debt conversion option
$
$
5,187
$
$
5,187 
Schedule of Measurement inputs
The following additional assumptions are used in the model:
March 31,
December 31,
 
2026
2025
Expected term (years)
5.0
5.0
Volatility
98.2%
96.4%
Risk-free interest rate
3.9%
3.7%
Expected dividend yield
—%
—%
Discount for lack of marketability
32.0%
31.0%
The following additional assumptions are used in the model:
March 31,
December 31,
 
2026
2025
Stated interest rate
5.0%
5.0%
Adjusted interest rate
1.5%
1.5%
Implied debt yield
14.0%
13.2%
Federal regulation probability
various
various
Year of event
various
various
The following table provides the assumptions regarding Level 2 fair value measurements inputs at their measurement dates:
March 31,
December 31,
 
2026
2025
Expected volatility
91.6%
89.8%
Expected term (years)
3.63
3.9
Risk-free interest rate
4.1%
3.9%
Expected dividend yield
—%
—%
Value of underlying share
C$1.00
C$0.50
Exercise price
C$2.00
C$2.00